Expression levels of 10 candidate genes in lung tissue of vaccinated and TB-infected cynomolgus macaques

Journal of Medical Primatology

Volumn 42, Issue 3, 2013, Pages 161-164

  Roodgar, Morteza ^a,b   Lackner, Andrew ^c   Kaushal, Deepak ^c   Sankaran, Sumathi ^d   Dandekar, Satya ^d   Satkoski Trask, Jessica ^a,b   Drake, Christiana ^a   Smith, David Glenn ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cynomolgus macaques; Gene expression; IL12; IL17; INOS; Tuberculosis

Indexed keywords

BCG VACCINE; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCR5 GENE; CONTROLLED STUDY; GENE; GENE EXPRESSION; IFNGAMMA GENE; IL10 GENE; IL12 GENE; IL17 GENE; IL1BETA GENE; IL6 GENE; INOS GENE; LUNG PARENCHYMA; LYMPH NODE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TLR2 GENE; TLR4 GENE; TNF ALPHA GENE; TUBERCULOSIS; VACCINATION;

ANIMALS; BCG VACCINE; CYTOKINES; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; LUNG; LYMPH NODES; MACACA FASCICULARIS; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TUBERCULOSIS, PULMONARY;

ANIMALIA; MACACA; MYCOBACTERIUM TUBERCULOSIS;

EID: 84877675699     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12040     Document Type: Article

References (25)

1. Capuano SV, 3rd, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, Bissel S, Fuhrman C, Klein E, Flynn JL: Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 2003; 71:5831-44.
2. Chan J, Tanaka K, Carroll D, Flynn J, Bloom B: Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:736-76.
3. Chan J, Xing Y, Magliozzo R, Bloom B: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175:1111-33.
4. Diedrich CR, Flynn JL: HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 2011; 79:1407-17.
5. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras T, Gaasterland T, Schoolnik G, Nathan C: Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001; 194:1123-63.
6. Flynn JAL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR: An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
7. Kanthaswamy S, Capitanio J, Dubay C, Ferguson B, Folks T, Ha J, Hotchkiss C, Johnson Z, Katze M, Kean L, Kubisch H, Lank S, Lyons L, Miller G, Nylander J, O'Connor D, Palermo R, Smith D, Vallender E, Wiseman R, Rogers J: Resources for genetic management and genomics research on non-human primates at the National Primate Research Centers (NPRCs). J Med Primatol 2009; 38(Suppl 1):17-40.
8. Keane J, Balcewicz-Sablinska M, Remold H, Chupp G, Meek B, Fenton M, Kornfeld H: Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997; 65:298-602.
9. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL: IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8:369-77.
10. Larsen MH, Biermann K, Chen B, Hsu T, Sambandamurthy VK, Lackner AA, Aye PP, Didier P, Huang D, Shao L, Wei H, Letvin NL, Frothingham R, Haynes BF, Chen ZW, Jacobs WR, Jr: Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine 2009; 27:4709-17.
11. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, Bah B, Benagiano M, Diallo A, Manetti R: Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32:1605-13.
12. MacMicking J, North R, LaCourse R, Mudgett J, Shah S, Nathan C: Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 1997; 94:5243-51.
13. Means T, Jones B, Schromm A, Shurtleff B, Smith J, Keane J, Golenbock D, Vogel S, Fenton M: Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166:4074-156.
14. Means T, Wang S, Lien E, Yoshimura A, Golenbock D, Fenton M: Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920-7.
15. Mehra S, Pahar B, Dutta NK, Conerly CN, Philippi-Falkenstein K, Alvarez X, Kaushal D: Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS ONE 2010; 5:e12266.
16. Nathan C: Inducible nitric oxide synthase in the tuberculous human lung. Am J Respir Crit Care Med 2002; 166:130-1.
17. Redford PS, Murray PJ, O'Garra A: The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 2011; 4:261-70.
18. Sánchez D, Rojas M, Hernández I, Radzioch D, García L, Barrera L: Role of TLR2- and TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death. Cell Immunol 2010; 260:128-64.
19. Scanga C, Mohan V, Tanaka K, Alland D, Flynn J, Chan J: The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun 2001; 69:7711-8.
20. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa M, Engele M, Sieling P, Barnes P, Rollinghoff M, Bolcskei P, Wagner M, Akira S, Norgard M, Belisle J, Godowski P, Bloom B, Modlin R: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001; 291:1544-51.
21. Trask JS, Smith D, Houghton P, Lerche N, Kanthaswamy S: Single Nucleotide Polymorphisms Reveal Patterns of Allele Sharing across a Species Boundary in Macaca mulatta and M. fascicularis. Am J Primatol 2013; 75:135-44.
22. Verhoeven D, Sankaran S, Silvey M, Dandekar S: Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4 + T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 2008; 82:4016-27.
23. Walzl G, Ronacher K, Hanekom W, Scriba T, Zumla A: Immunological biomarkers of tuberculosis. Nat Rev Immunol 2011; 11:343-97.
24. Wozniak TM, Saunders BM, Ryan AA, Britton WJ: Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010; 78:4187-94.
25. Yuan J, Reed A, Chen F, Stewart C: Statistical analysis of real-time PCR data. BMC Bioinformatics 2006; 7:85.